| |
|
Action |
Time |
Lead |
| 1 |
Apologies for absence |
|
10.00 |
|
| 2 |
Minutes of the meeting of the Board of Directors held on Monday
28th May, 2012 |
Encl to approve |
10.05 |
|
| 3 |
Matters arising from the Minutes of the meeting of the Board of
Directors held on 28th May, 2012 |
|
10.10 |
|
| 4 |
Board Action
Points |
|
|
|
| 5 |
To receive Declarations of Interest fromDirectors and
Officers |
|
10.15 |
Chair |
| 6 |
Consultant Appointments |
Verbal report |
10.20 |
Chief Executive |
| 7 |
Quality And Safety |
|
|
|
| 7.1 |
Quality Accounts 2011/12 and Trust Annual Report 2011/12 |
To follow |
10.25 |
Chief Nursing Officer |
| 7.2 |
Quality and Safety
Report |
Encl to note |
|
Chief Nursing Officer |
| 7.3 |
Report of the Parliamentary Health Service Ombudsman ‘Care and
Compassion?’ Published in February 2011 - RWHT gap analysis and
updated actions June 2012 |
Encl to note |
|
Chief Nursing Officer |
| 7.4 |
Workforce Review of Nursing and Midwifery
Stage I |
Encl to approve |
|
Chief Nursing Officer |
| 7.5 |
Falls
Prevention |
Encl to note |
|
Chief Nursing Officer |
| 7.6 |
Update on Dementia
Training |
Encl to note |
|
Chief Nursing Officer |
| 8 |
Business Planning |
|
|
|
| 8.1 |
Capital Programme 2012/2013 – Month 2 |
Encl to note |
11.20 |
Chief Financial Officer |
| 8.2 |
Any Qualified Provider (AQP) Arrangements 2012/13 |
Encl to note |
|
Director of Planning and Contracting |
| 8.3 |
Report of the Change Programme Board |
Encl to note |
|
Director of Planning and Contracting |
| 9 |
Governance |
|
|
|
| 9.1 |
Board Assurance Framework/Trust Risk Register |
Encl to note |
11.35 |
Chief Operating Officer |
| 9.2 |
Board Assurance Committee Annual Report |
Encl to note |
|
Balsinder Jaspal-Mander |
| 9.3 |
Trust Management Team – Terms of Reference |
Encl to approve |
|
Chief Executive |
| 10 |
Operational Performance |
|
|
|
| 10.1 |
Performance
Report |
Encl to note |
12.00 |
Chief Nursing Officer |
| 11 |
Finance and Information |
|
|
|
| 11.1 |
Financial Position of the
Trust May 2012 (Month 2) |
Encl to note |
12.10 |
Chief Financial Officer |
| 11.2 |
External
Audit – Final ISA260 |
Encl to note |
|
Chief Financial Officer |
| 11.3 |
External Audit – Management Representation Letter |
Encl to approve |
|
Chief Financial Officer |
| 11.4 |
Financial summary of year ended 31 March 2012 based upon Annual
Accounts Submission |
|
|
Chief Financial Officer |
| 11.5 |
Audited
Annual Accounts 2011/12 |
Encl to approve |
|
Chief Financial Officer |
| 11.6 |
Procurement
Strategy |
Encl to approve |
|
Chief Financial Officer |
| 12 |
Human Resources |
|
|
|
| 12.1 |
HR Strategy Implementation Plan Progress
Review – April 2012 |
Encl to note |
12.45 |
Director of Human Resources |
| 12.2 |
2011 National CQC Staff Survey Results |
Encl to note |
|
Director of Human Resources |
| 12.3 |
Health and Wellbeing Project update |
Encl to note |
|
Director of Human Resources |
| 13 |
Medical Director |
|
|
|
| 13.1 |
7 Day Working - update |
Encl to note |
12.55 |
Medical Director |
| 14 |
Feedback From Board Sub-Committees |
|
|
|
| 14.1 |
Minutes of the meeting of the Trust Management Team held on 20th
April, 2012 |
Encl to note |
1.00 |
Chief Executive |
| 14.2 |
Minutes of the meeting of the Infection Prevention Committee
held on 27th April 2012 |
To follow |
|
Chief Executive |
| 14.3 |
Chairman’s Summary of the meeting of the Audit Committee held
on 7 June 2012 |
Oral report |
|
Keith Bryan |
| 14.4 |
Minutes of the meeting of the Board Assurance Committee held on 26
April 2012 (joint meeting with the Audit Committee) |
Encl to note |
|
Balsinder Jaspal-Mander |
| 15 |
General Business |
|
|
|
| 15.1 |
Approved Policies:
Policies approved by the Trust Management Team at the meeting held
on 22nd June, 2012 |
To note |
1.05 |
Chief Executive |
| 15.2 |
Matters raised by members of the general public and
commissioners |
|
|
|
| 15.3 |
Date and time of next meeting:
Monday 23rd July, 2012 at 10.00 a.m. in the Clinical Skills and
Corporate Services Centre, New Cross Hospital |
|
|
|
| 15.4 |
To consider a resolution that representatives of the press and
other members of the public be excluded from the remainder of this
meeting, having regard to the confidential nature of the business
to be transacted, publicity on which would be prejudicial to the
public interest. |
|
|
|